In her new role, Parkler will hold overall commercial responsibility for Pfizer’s operations in several European markets and lead the design of the operating model for Pfizer Global Hospital & Biosimilars in Europe. She will remain based in Stockholm and will continue as VD (CEO) of Pfizer AB for the time being.

“After many years leading Pfizer Sweden, I am both proud and inspired to take on a broader European assignment. My commitment to patients, innovation, and strong healthcare will continue to be an important driving force in my new role,” says Parkler.

Caglar Ceritoglu – Interim Country Leas in Sweden

Caglar Ceritoglu, North Europe Cluster President, will step in as Acting Country Lead in Sweden. He will serve as Acting Country Lead alongside his current role as North Europe Cluster President.

“Sweden is an important part of our business in Northern Europe. I look forward to working even more closely with the Swedish organization and our colleagues during this period. Our focus remains the same: to help ensure patients have access to medical innovation and to continue being a long-term, constructive partner to Swedish healthcare and life science,” says Ceritoglu.